Awasthi S - Search Results

1

Rapid and accurate detection of herpes simplex virus type 2 using a low-cost electrochemical biosensor.

de Lima LF, Ferreira AL, Awasthi S, Torres MDT, Friedman HM, Cohen GH, de Araujo WR, de la Fuente-Nunez C. de Lima LF, et al. Among authors: awasthi s. Cell Rep Phys Sci. 2023 Sep 20;4(9):101513. doi: 10.1016/j.xcrp.2023.101513. Epub 2023 Aug 23. Cell Rep Phys Sci. 2023. PMID: 38239491 Free PMC article.

2

Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9.

McGraw HM, Awasthi S, Wojcechowskyj JA, Friedman HM. McGraw HM, et al. Among authors: awasthi s. J Virol. 2009 Sep;83(17):8315-26. doi: 10.1128/JVI.00633-09. Epub 2009 Jul 1. J Virol. 2009. PMID: 19570876 Free PMC article.

3

The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.

Lubinski JM, Lazear HM, Awasthi S, Wang F, Friedman HM. Lubinski JM, et al. Among authors: awasthi s. J Virol. 2011 Apr;85(7):3239-49. doi: 10.1128/JVI.02509-10. Epub 2011 Jan 12. J Virol. 2011. PMID: 21228231 Free PMC article.

4

A paradigm shift: vaccine-induced antibodies as an immune correlate of protection against herpes simplex virus type 1 genital herpes.

Awasthi S, Friedman HM. Awasthi S, et al. J Infect Dis. 2014 Mar;209(6):813-5. doi: 10.1093/infdis/jit658. Epub 2013 Nov 27. J Infect Dis. 2014. PMID: 24285847 No abstract available.

5

Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine.

Awasthi S, Belshe RB, Friedman HM. Awasthi S, et al. J Infect Dis. 2014 Aug 15;210(4):571-5. doi: 10.1093/infdis/jiu177. Epub 2014 Mar 20. J Infect Dis. 2014. PMID: 24652496 Free PMC article. Clinical Trial.

6

Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.

Awasthi S, Huang J, Shaw C, Friedman HM. Awasthi S, et al. J Virol. 2014 Aug;88(15):8421-32. doi: 10.1128/JVI.01130-14. Epub 2014 May 14. J Virol. 2014. PMID: 24829358 Free PMC article.

7

Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.

Awasthi S, Shaw C, Friedman H. Awasthi S, et al. Expert Rev Vaccines. 2014 Dec;13(12):1475-88. doi: 10.1586/14760584.2014.951336. Epub 2014 Aug 20. Expert Rev Vaccines. 2014. PMID: 25138572 Review.

8

Molecular association of herpes simplex virus type 1 glycoprotein E with membrane protein Us9.

Awasthi S, Friedman HM. Awasthi S, et al. Arch Virol. 2016 Nov;161(11):3203-13. doi: 10.1007/s00705-016-3028-z. Epub 2016 Aug 27. Arch Virol. 2016. PMID: 27568015 Free PMC article.

9

A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model.

Awasthi S, Hook LM, Shaw CE, Friedman HM. Awasthi S, et al. Hum Vaccin Immunother. 2017 Dec 2;13(12):2785-2793. doi: 10.1080/21645515.2017.1323604. Epub 2017 May 8. Hum Vaccin Immunother. 2017. PMID: 28481687 Free PMC article.

10

Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.

Hook LM, Cairns TM, Awasthi S, Brooks BD, Ditto NT, Eisenberg RJ, Cohen GH, Friedman HM. Hook LM, et al. Among authors: awasthi s. PLoS Pathog. 2018 May 23;14(5):e1007095. doi: 10.1371/journal.ppat.1007095. eCollection 2018 May. PLoS Pathog. 2018. PMID: 29791513 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,041 results

Search Page